Lead Medical closes multi-million-yuan Series A2 round led by SIG

Medical technology service company Lead Medical has raised tens of millions of yuan in its Series A2 round of financing. The round was led by SIG, and joined by Taya Venture Capital. Proceeds from this round of financing will be used to accelerate the layout of Lead Medical in the Chinese market.

Medical technology service company Lead Medical has raised tens of millions of yuan in its Series A2 round of financing. The round was led by SIG, and joined by Taya Venture Capital. Proceeds from this round of financing will be used to accelerate the layout of Lead Medical in the Chinese market.

In October of last year, Lead Medical had completed its Series A1 round raising tens of millions of yuan.

Founded in 2015, Lead Medical is mainly engaged in intelligent medical innovation and data integration services in the fields of cardiology, obstetrics and gynecology.

From the screening, outpatient diagnosis and treatment, surgery to follow-up and other clinical paths, it cuts into the in-depth services of single department and single disease, use intelligent medical and data services to connect the upstream and downstream links of the single department and single disease, and complete the realization from data integration to data application to improve the complicated work status of medical staff.

At present, the intelligent medical services provided by Lead Medical have been relatively mature in improving the efficiency and quality of the single-department sector.

Since last year, it has begun market-oriented deployment in top-tier hospitals in various provinces in China. In 2020, the company will fully accelerate its business layout in first- and second-tier cities in China.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/05/27/lead-medical-closes-multi-million-yuan-series-a2-round-led-by-sig/.

Leave a Reply

Please Login to Comment